Skip to main content

Table 3 Mortality and duration of major therapeutic interventions used, and length of stay in ICU and hospital for patients treated with or without IVIgG

From: Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock

 

Before propensity score matching

After propensity score matching

IVIgG(+)

(n = 960)

IVIgG(–)

(n = 2158)

p value

IVIgG(+)

(n = 653)

IVIgG(–)

(n = 653)

p value

Mortality

 ICU mortality (%)

219 (22.8)

376 (17.4)

<0.001

137 (21.0)

118 (18.1)

0.185

 In-hospital mortality (%)

330 (34.4)

670 (31.0)

0.066

215 (32.9)

187 (28.6)

0.093

Duration of major intervention uses up to 28 days and length of stay (days)

 Duration of mechanical ventilation

5 (2–12)

3 (0–9)

<0.001

5 (2–12)

3 (0–9)

<0.001

 Duration of vasoactive drugs

3 (2–7)

3 (0–5)

<0.001

3 (2–6.5)

3 (1–6)

0.004

 Duration of renal replacement therapy

1 (0–5)

0 (0–2)

<0.001

0 (0–4)

0 (0–2)

<0.001

 Length of stay in ICU

8 (4–15)

6 (3–13)

<0.001

8 (4–15)

7 (4–13)

0.012

 Length of stay from ICU admission to discharge

28 (14–55)

27 (13–53)

0.310

28 (14–50)

27 (13–52.5)

0.743

  1. ICU intensive care unit, IVIgG intravenous immunoglobulin G